Comments on: Excellent Q2 nos from Shilpa Medicare http://dalaal-street.com/shilpa-medicare-q2-numbers/ Monies and Conversations Mon, 06 Sep 2010 15:12:00 +0000 hourly 1 http://wordpress.org/?v=3.0.1 By: Ayush Mittal http://dalaal-street.com/shilpa-medicare-q2-numbers/#comment-1493 Ayush Mittal Wed, 27 Jan 2010 08:39:31 +0000 http://dalaal-street.com/excellent-q2-nos-from-shilpa-medicare/#comment-1493 Dear Manmohan, As per my reading, Shilpa has posted excellent Q3 nos. I'm more than happy with the nos :) Stock might be down due to the fall in market and sentiment, leading to profit booking (stock has had a fantastic run up) Keep patience. If the company continues to maintain margins and grow like before, the stock should cross 300-350 levels also. Regards, Dear Manmohan,

As per my reading, Shilpa has posted excellent Q3 nos. I’m more than happy with the nos :)

Stock might be down due to the fall in market and sentiment, leading to profit booking (stock has had a fantastic run up)

Keep patience. If the company continues to maintain margins and grow like before, the stock should cross 300-350 levels also.

Regards,

]]> By: Ayush Mittal http://dalaal-street.com/shilpa-medicare-q2-numbers/#comment-2199 Ayush Mittal Wed, 27 Jan 2010 08:39:00 +0000 http://dalaal-street.com/excellent-q2-nos-from-shilpa-medicare/#comment-2199 Dear Manmohan, As per my reading, Shilpa has posted excellent Q3 nos. I'm more than happy with the nos :) Stock might be down due to the fall in market and sentiment, leading to profit booking (stock has had a fantastic run up) Keep patience. If the company continues to maintain margins and grow like before, the stock should cross 300-350 levels also. Regards, Dear Manmohan,

As per my reading, Shilpa has posted excellent Q3 nos. I’m more than happy with the nos :)

Stock might be down due to the fall in market and sentiment, leading to profit booking (stock has had a fantastic run up)

Keep patience. If the company continues to maintain margins and grow like before, the stock should cross 300-350 levels also.

Regards,

]]> By: Manmohan http://dalaal-street.com/shilpa-medicare-q2-numbers/#comment-1492 Manmohan Wed, 27 Jan 2010 08:34:33 +0000 http://dalaal-street.com/excellent-q2-nos-from-shilpa-medicare/#comment-1492 Hi Ayush, What is wrong with Shilpa's Q3 numbers? The stock is hammered and is at 10% lower circuit. Also Vishnukant Bhutada, MD , Shilpa Med had mentioned in CNBC that they have patent molecules lined up till 2017 and will be able to maintain OPM. Regards, Manmohan Hi Ayush,

What is wrong with Shilpa’s Q3 numbers? The stock is hammered and is at 10% lower circuit.

Also Vishnukant Bhutada, MD , Shilpa Med had mentioned in CNBC that they have patent molecules lined up till 2017 and will be able to maintain OPM.

Regards,
Manmohan

]]> By: Manmohan http://dalaal-street.com/shilpa-medicare-q2-numbers/#comment-2198 Manmohan Wed, 27 Jan 2010 08:34:00 +0000 http://dalaal-street.com/excellent-q2-nos-from-shilpa-medicare/#comment-2198 Hi Ayush, What is wrong with Shilpa's Q3 numbers? The stock is hammered and is at 10% lower circuit. Also Vishnukant Bhutada, MD , Shilpa Med had mentioned in CNBC that they have patent molecules lined up till 2017 and will be able to maintain OPM. Regards, Manmohan Hi Ayush,

What is wrong with Shilpa’s Q3 numbers? The stock is hammered and is at 10% lower circuit.

Also Vishnukant Bhutada, MD , Shilpa Med had mentioned in CNBC that they have patent molecules lined up till 2017 and will be able to maintain OPM.

Regards,
Manmohan

]]>